Immunizing Older Individuals Requires Flexibility, Nuance
Pharmacy Times
JANUARY 2, 2023
When it comes to vaccination efforts, remember that patients 65 years or older are not a homogeneous group.
January, 2023
121 
How decentralised storage networks can change the game for the pharmaceutical industry
Pharma Phorum
JANUARY 3, 2023
The way pharmaceutical companies manage data carries inherent risks, as exemplified by the constant scandals about data breaches. Is there anything that can be done about this?
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Companies Partner Up on Sustainable Pharma Packaging
Pharmaceutical Commerce
JANUARY 3, 2023
Collaboration aims to decrease environmental burden in the space.
Governing Principles for Successful Biotechnology Companies
PharmExec
JANUARY 18, 2023
Pete O'Heeron, founder, chairman, and CEO of FibroBiologics, explains the key principles that biotechnology companies should follow.
AstraZeneca’s newest asthma launch fills a gap as generics chip away at respiratory flagships
PharmaVoice
JANUARY 24, 2023
A longtime leader in the respiratory space, AstraZeneca has hammered another stake in the ground with its newest asthma treatment, Airsupra
Amazon Pharmacy rolls out service for unlimited generic drug prescriptions for $5 a month
Fierce Healthcare
JANUARY 23, 2023
Amazon Pharmacy rolls out service for unlimited generic drug prescriptions for $5 a month hlandi Mon, 01/23/2023 - 22:15
Wearable Device Accurately Tracks Heart Failure Progression
Pharmacy Times
JANUARY 10, 2023
Approximately half of patients with heart failure do not require an implantable monitoring device or do not qualify for thoracic monitoring.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
FDA pulls AZ’s Evusheld for COVID, citing lack of efficacy
Pharma Phorum
JANUARY 27, 2023
AstraZeneca’s revenue boost from COVID-19 therapy Evusheld looks set to be curbed early, as the FDA withdraws authorisation for the antibody on the grounds that it is ineffective against most subvariants now circulating in the US.
Stars Aligned for Pricing Model? Value-Based Contracts May be Poised for Takeoff
PharmExec
JANUARY 11, 2023
As new forms of cell and gene therapies continue to be developed, life sciences companies and payers need to find alternative ways to pay for these expensive treatments. Value-based contracts, though slow to gain traction so far, may provide the solution these groups are looking for.
Forks in the road lead one medical expert to a ‘game changing’ liver treatment
PharmaVoice
JANUARY 3, 2023
Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis
The impact of climate change on the pharma supply chain
Pharmaceutical Technology
JANUARY 20, 2023
Pharmaceutical supply chains are extremely vulnerable to the effects of climate change and face many challenges from sourcing to distribution.
Study Shows That Breast Milk of Those Vaccinated Against COVID-19 Protects Infants
Pharmacy Times
JANUARY 20, 2023
Antibodies help neutralize the virus, though the levels decrease at the 6-month mark, data indicate.
2023 Fundraising Challenges
NF2 BioSolutions
JANUARY 4, 2023
We are doing 2 fundraising challenges throughout the year this year and you can partake in any whenever you like, get everyone involved from mums, dads, kids, grandparents, aunts, uncles, neighbours, friends and work colleagues. HAVE FUN AND RAISE FUNDS FOR NF2 RESEARCH! CAKE BAKE & COFFEE.
Can machine learning accelerate drug formulation?
Outsourcing Pharma
JANUARY 24, 2023
Research emerging from the University of Toronto found that using machine learning models was able to guide the design of long-acting drug formulations. Clinical Development
Type 1 Diabetes: A Potential Cure
PharmExec
JANUARY 6, 2023
One company pursues a program for a technology they believe is a potential cure for Type 1 diabetes.
Space — the next frontier in drug development
PharmaVoice
JANUARY 12, 2023
Merck, Bristol Myers Squibb and others are taking small R&D steps in space that could lead to giant leaps for patients
Dollar General pilots mobile clinics as it targets a bigger presence in healthcare
Fierce Healthcare
JANUARY 20, 2023
Dollar General pilots mobile clinics as it targets a bigger presence in healthcare hlandi Fri, 01/20/2023 - 18:25
FDA Approved IND for CAR T Cell That Target Metastases-Causing Breast Cancer Tumor
Pharmacy Times
JANUARY 16, 2023
The head of the CAR T cell antibody can recognize and target the growth factor in its tumor microenvironment.
BMS settles lawsuit with two fired employees who refused COVID vaccines
Fierce Pharma
JANUARY 26, 2023
BMS settles lawsuit with two fired employees who refused COVID vaccines kdunleavy Thu, 01/26/2023 - 14:30
Can the FDA keep the momentum going for rare disease drug approvals?
Pharmaceutical Technology
JANUARY 22, 2023
In 2022, the FDA approved only 37 new medicines, an underwhelming number compared to 98 in 2018. However, while only around 34% of the approvals in 2018 were for orphan drugs, 54% new approvals in 2022 were for drugs to treat rare diseases.
Cybersecurity Threats & Pharma
PharmExec
JANUARY 11, 2023
The steps companies can take now to better protect themselves and their data.
FDA’s 2022 drug approvals fall short of recent norms
PharmaVoice
JANUARY 19, 2023
The U.S. agency’s lower number of novel drug approvals followed several controversies surrounding a 2021 Alzheimer’s approval
UnitedHealthcare launches behavioral health coaching program for commercial plans
Fierce Healthcare
JANUARY 19, 2023
UnitedHealthcare launches behavioral health coaching program for commercial plans pminemyer Thu, 01/19/2023 - 15:05
Speech Therapy May Effectively Address Long COVID Communication Issues
Pharmacy Times
JANUARY 3, 2023
In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.
JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint
Fierce Pharma
JANUARY 9, 2023
JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint. esagonowsky. Mon, 01/09/2023 - 09:55
Google and DeepMind share work on medical chatbot Med-PaLM
Pharma Phorum
JANUARY 6, 2023
Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients.
Q&A with Kelly Baker, CFO of Eversana
PharmExec
JANUARY 4, 2023
Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.
Nonprofits are bridging R&D’s valley of death
PharmaVoice
JANUARY 4, 2023
How charitable firms such as Advancium are helping to right the market wrongs of drug development
New Jefferson Health program enables clinical, academic nurses to partner on research
Fierce Healthcare
JANUARY 18, 2023
New Jefferson Health program enables clinical, academic nurses to partner on research agliadkovskaya Wed, 01/18/2023 - 14:16
Study: Empagliflozin Can Slow Progression of Chronic Kidney Disease to Kidney Failure
Pharmacy Times
JANUARY 19, 2023
Data from a randomized clinical trial supports previous clinical findings on SGLT2 inhibitors and their ability to slow the progression of chronic kidney disease.
Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine
Fierce Pharma
JANUARY 25, 2023
Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine kdunleavy Wed, 01/25/2023 - 13:16
J&J copay lawsuit against drug benefit firm gets green light
Pharma Phorum
JANUARY 27, 2023
Johnson & Johnson has been cleared to continue a lawsuit filed last year against drug benefit programme SaveOnSP, which claims it defrauded a payment assistance programme for patients out of “at least $100 million.”
Has the Glass Ceiling Finally Been Broken at the Big Four Consulting Firms?
PharmExec
JANUARY 18, 2023
Author Deepa Purushothaman discusses the progress of women and women of color in corporate America.
Woman of the Week: Form Bio’s Claire Aldridge
PharmaVoice
JANUARY 11, 2023
The chief strategy officer of Form Bio is harnessing the new company’s computing power and bioinformatics to spur a genomic revolution
Healthcare ranked lowest for employee satisfaction, Qualtrics survey finds
Fierce Healthcare
JANUARY 18, 2023
Healthcare ranked lowest for employee satisfaction, Qualtrics survey finds aburky Wed, 01/18/2023 - 16:40
HSV Offers Promising Target for Preventive, Therapeutic Vaccines
Pharmacy Times
JANUARY 17, 2023
Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.
CDC probes possible safety risk for Pfizer's new COVID shot, sees no need to change vaccine practices
Fierce Pharma
JANUARY 17, 2023
CDC probes possible safety risk for Pfizer's new COVID shot, sees no need to change vaccine practices. zbecker. Tue, 01/17/2023 - 11:49
Let's personalize your content